DLHAX
Price
$22.38
Change
+$0.19 (+0.86%)
Updated
Apr 17 closing price
Net Assets
641.71M
FBTAX
Price
$23.78
Change
+$0.38 (+1.62%)
Updated
Apr 17 closing price
Net Assets
1.39B
Ad is loading...

DLHAX vs FBTAX

Header iconDLHAX vs FBTAX Comparison
Open Charts DLHAX vs FBTAXBanner chart's image
Macquarie Healthcare A
Price$22.38
Change+$0.19 (+0.86%)
VolumeN/A
Net Assets641.71M
Fidelity Advisor Biotechnology A
Price$23.78
Change+$0.38 (+1.62%)
VolumeN/A
Net Assets1.39B
DLHAX vs FBTAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLHAX vs. FBTAX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHAX is a Hold and FBTAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.39B vs. DLHAX (642M). FBTAX pays higher dividends than DLHAX: FBTAX (2.97) vs DLHAX (0.10). DLHAX was incepted earlier than FBTAX: DLHAX (18 years) vs FBTAX (24 years). DLHAX (1.25) is less costly to investors than FBTAX (0.96). FBTAX is a more actively managed with annual turnover of: 73.00 vs. DLHAX (5.00). DLHAX (6%) and FBTAX (6%) have equivalent initial investment costs. FBTAX has a lower initial minimum investment than DLHAX: FBTAX (0) vs DLHAX (1000). DLHAX annual gain was more profitable for investors over the last year : -13.38 vs. FBTAX (-14.81). DLHAX return over 5 years is better than : -11.51 vs. FBTAX (-12.93).
DLHAXFBTAXDLHAX / FBTAX
Total Expense Ratio1.210.96126%
Annual Report Gross Expense Ratio1.250.96130%
Fund Existence18 years24 years-
Gain YTD-5.768-14.00241%
Front Load6%6%100%
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets642M1.39B46%
Annual Yield % from dividends0.102.973%
Returns for 1 year-13.38-14.8190%
Returns for 3 years-18.821.10-1,715%
Returns for 5 years-11.51-12.9389%
Returns for 10 years10.32-16.28-63%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ROFCX9.410.09
+0.97%
Royce Small-Cap Opportunity Consult
PUVCX40.43N/A
N/A
Putnam International Capital Opp C
JLCAX17.61N/A
N/A
JPMorgan US Large Cap Core Plus A
CENNX12.32N/A
N/A
Centerstone Investors C
RNGFX55.52-0.23
-0.41%
American Funds New Economy R5